Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-11-28

Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of CyPep-1 in Combination With Pembrolizumab for the Treatment of Advanced or Metastatic Cancers [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 study evaluating the safety and preliminary efficacy of CyPep-1 in combination with pembrolizumab for advanced or metastatic cancers; the trial has co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CyPep-1
  • KEYTRUDA (PEMBROLIZUMAB)

Snippet

Sponsor: Cytovation AS | Conditions: Advanced Head and Neck Squamous Cell Carcinoma, Advanced Breast Cancer | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2025-11-28